16 Nov

Stem cell-based model of the blood-brain barrier

A better understanding of the blood-brain barrier (BBB) is key for developing treatments for disease like MS and Alzheimer’s. In a collaboration with AstraZeneca, KTH, Karolinska Institute and University of Skövde  we recently published an article studying the use of human stem cells to generate in vitro models of the BBB. More specifically, we studied  the barrier properties and transcriptome of iPSC-derived models. Check out the full article published in Stem Cells (pubmed).